SENP1 desensitizes hypoxic ovarian cancer cells to cisplatin by up-regulating HIF-1α

Sci Rep. 2015 Nov 9:5:16396. doi: 10.1038/srep16396.

Abstract

Hypoxia-inducible factor 1 alpha (HIF-1α) is closely related to chemoresistance of ovarian cancers. Although it is reported that HIF-1α can be regulated by Sentrin/SUMO-specific protease 1 (SENP1), the effects of SENP1 on HIF-1α is still controversial. In this study, we identified that SENP1 positively regulated the expression of HIF-1α by deSUMOylation and weakened the sensitivity of hypoxic ovarian cancer cells to cisplatin. These results indicate that SENP1 is a positive regulator of HIF-1α and plays a negative role in ovarian cancer chemotherapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Cell Hypoxia
  • Cell Line, Tumor
  • Cisplatin / pharmacology*
  • Cysteine Endopeptidases
  • Drug Resistance, Neoplasm* / genetics
  • Endopeptidases / genetics*
  • Endopeptidases / metabolism
  • Female
  • Gene Expression Regulation, Neoplastic / drug effects*
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit / genetics*
  • Hypoxia-Inducible Factor 1, alpha Subunit / metabolism
  • Ovarian Neoplasms / genetics*
  • Ovarian Neoplasms / metabolism
  • Sumoylation

Substances

  • Antineoplastic Agents
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Endopeptidases
  • SENP1 protein, human
  • Cysteine Endopeptidases
  • Cisplatin